Original Research

The absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles is not significantly impacted by the use of myeloid growth factors and predicts clinical outcomes in classical Hodgkin lymphoma regardless of their use

Kaufman GP, Ristow KM, Markovic SN, Porrata LF

Blood and Lymphatic Cancer: Targets and Therapy 2014, 4:39-44

Published Date: 23 July 2014